Confirmed Speakers
Tentative Title | Presenter | Affiliation |
---|---|---|
Biofilms in Bone Tumor Patients: Quantitative Science Chasing Clinical Imperatives | Nick Berthal (MD) | UCLA |
Case studies of infection associated with soft-tissue biomaterials | Peter Taub, MD | Mt. Sinai |
OR Contamination and Device-Associated Infection | Kees Poelstra (MD, PhD) | Rothman Orthopaedics |
Possible Intervention Points in the Development of Gram-Negative Biofilms | Karin Sauer | Binghamton University |
Reading the map: Effects of topography on biofilm initiation and development | Dacheng Ren | Syracuse University |
Harnessing macrophage behavior for chronic wound healing | Kara Spiller | Drexel University |
To touch or not to touch: mechanism of antibacterial contact transfer | Shikha Nangia | Syracuse University |
In vivo infection models - filling the gap between in vitro and clinical | Tom Schaer | UPenn Vet School |
Antimicrobial Devices: Challenges and Opportunities in 2023 and beyond | Scott Phillips | FDA |
ISO/ASTM working groups on the antimicrobial properties of implants | John Rose (tentative) | Smith & Nephew |
Commercializing antimicrobial surfaces requires technology and claim-specific testing | Jordan Katz | Orthobond |
Detecting Device Infection – Progress and Challenges in Orthopedics | Li Yang | Zimmer Biomet |
Physical removal of biofilms via viscoelastic fluids: principles & biomedical applications | Mohammed Labib | Novaflux |
Commercializing biomimetic antimicrobial peptoids | Kent Kirschenbaum | Maxwell Biosciences/NYU |
Efforts to Translate Cellulose-Based Hydrogels to the Clinic | Steve Nicoll | City College |
A career-long perspective of biofilms & device infection: where might we be going | Henk Busscher | University Medical Center Groningen |